Download Citation
Article Source:
Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma
Xu X,
Tang L,
Piao X,
Zhan S,
Chen Y,
et al.
(2026)
Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
PLOS ONE 21(5): e0349044.
https://doi.org/10.1371/journal.pone.0349044